International Patent: MRX-2843 OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR USE IN THE TREATMENT OF A TUMOUR THAT EXPRESSES AN ACTIVATED MERTK RECEPTOR.

GENEVA, Aug. 14 -- UNIVERSITY OF PLYMOUTH filed a patent application (EP2026/053285) for “MRX-2843 OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF FOR USE IN THE TREATMENT OF A TUMOUR THAT EXPRESSES AN ACTIVATED MERTK RECEPTOR.”. With publication no. WO/2026/167223, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/519

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....